Niagen Bioscience(NAGE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NAGE Niagen Bioscience

Trading 08-03 09:52:56 EDT

3.53

+0.13

+3.82%

High3.58	Low3.49	Vol88.22K
Open3.49	D1 Closing3.40	Amplitude2.65%
Mkt Cap282.12M	Tradable Cap198.90M	Total Shares79.92M
T/O310.83K	T/O Rate0.16%	Tradable Shares56.35M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NAGE","market":"US","secType":"STK","nameCN":"Niagen Bioscience","latestPrice":3.53,"timestamp":1785765175383,"preClose":3.4,"halted":0,"volume":88223,"delay":0,"changeRate":0.03823529411764703,"floatShares":56345168,"shares":79919957,"eps":0.210015,"marketStatus":"Trading","change":0.13,"latestTime":"08-03 09:52:56 EDT","open":3.49,"high":3.58,"low":3.49,"amount":310830.7495862,"amplitude":0.026471,"askPrice":3.54,"askSize":600,"bidPrice":3.52,"bidSize":616,"shortable":3,"etf":0,"ttmEps":0.210015,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1785787200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":3.4,"preHourTrading":{"tag":"盘前","latestPrice":3.5,"preClose":3.4,"latestTime":"09:29 EDT","volume":766,"amount":2642.219718,"timestamp":1785763799516,"change":0.1,"changeRate":0.029412,"amplitude":0.070588},"postHourTrading":{"tag":"盘后","latestPrice":3.4,"preClose":3.4,"latestTime":"19:37 EDT","volume":1348,"amount":4581.83,"timestamp":1785541023704,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.521045,"impliedVol":1.8615,"impliedVolPercentile":0.7968},"requestUrl":"/m/hq/s/NAGE/wiki","defaultTab":"wiki","newsList":[{"id":"2656794493","title":"Niagen Bioscience Taps Evotec to Advance Preclinical Development of Nb4168 Rare-Disease Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2656794493","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656794493?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:33","pubTimestamp":1785760393,"startTime":"0","endTime":"0","summary":"Niagen Bioscience taps Evotec to advance preclinical development of NB4168 rare-disease candidateNiagen Bioscience selected Evotec as a contract research partner to advance preclinical development of ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL4wjyhJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","NAGE","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656379108","title":"Niagen Bioscience - Plans Ind Application to FDA for Nb4168","url":"https://stock-news.laohu8.com/highlight/detail?id=2656379108","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656379108?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:33","pubTimestamp":1785760382,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN44019B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","NAGE","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656734391","title":"Niagen Bioscience Inc Expected to Post Earnings of 2 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656734391","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656734391?lang=en_us&edition=fundamental","pubTime":"2026-08-01 05:11","pubTimestamp":1785532266,"startTime":"0","endTime":"0","summary":"Niagen Bioscience Inc <NAGE.OQ> expected to post earnings of2cents a share - Earnings PreviewNiagen Bioscience IncNAGE.OQNAGE.Ois expected to  show a fall in quarterly revenue when it reports  results","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL8N43X3AR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4183","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654002023","title":"Niagen Bioscience announces publication on muscle epigenetic age","url":"https://stock-news.laohu8.com/highlight/detail?id=2654002023","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654002023?lang=en_us&edition=fundamental","pubTime":"2026-07-28 20:41","pubTimestamp":1785242484,"startTime":"0","endTime":"0","summary":"Niagen Bioscience (NAGE) announced the publication of a new peer-reviewed analysis of past clinical studies in Aging Cell examining the effects of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-announces-publication-on-muscle-epigenetic-age-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-announces-publication-on-muscle-epigenetic-age-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4183","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654004720","title":"Niagen Bioscience Reports Analysis Finds Niagen NR Cuts Muscle Epigenetic Age by About 2.5 Years in 5-month Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2654004720","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654004720?lang=en_us&edition=fundamental","pubTime":"2026-07-28 20:32","pubTimestamp":1785241943,"startTime":"0","endTime":"0","summary":"Niagen Bioscience reports analysis finds Niagen NR cuts muscle epigenetic age by about 2.5 years in 5-month trialNiagen Bioscience flagged a newly published peer-reviewed analysis in Aging Cell re-exa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDL27jx7V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4121","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654498260","title":"Niagen Bioscience (NAGE) Gets a Buy from Roth MKM","url":"https://stock-news.laohu8.com/highlight/detail?id=2654498260","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654498260?lang=en_us&edition=fundamental","pubTime":"2026-07-27 22:45","pubTimestamp":1785163533,"startTime":"0","endTime":"0","summary":"In a report released today, Sean McGowan from Roth MKM maintained a Buy rating on Niagen Bioscience, with a price target of $12.00. According to Ti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/niagen-bioscience-nage-gets-a-buy-from-roth-mkm-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/niagen-bioscience-nage-gets-a-buy-from-roth-mkm-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4183","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654127010","title":"Niagen Bioscience CEO to Speak at Canaccord Genuity Growth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2654127010","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654127010?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:33","pubTimestamp":1785155614,"startTime":"0","endTime":"0","summary":"Niagen Bioscience CEO to speak at Canaccord Genuity Growth ConferenceNiagen Bioscience executives will attend Canaccord Genuity’s 46th Annual Growth Conference in Boston on Aug. 11-13, 2026.CEO Rob Fr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nNDL4Ch5Gj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4121","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130239342","title":"Niagen Bioscience to Announce Second Quarter Financial Results on August 4","url":"https://stock-news.laohu8.com/highlight/detail?id=1130239342","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130239342?lang=en_us&edition=fundamental","pubTime":"2026-07-21 21:51","pubTimestamp":1784641890,"startTime":"0","endTime":"0","summary":"Biotechnology company Niagen Bioscience (Nasdaq: NAGE), which focuses on NAD+ science and healthy aging, has announced it will release its second quarter financial results after the U.S. market...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSET","BK4121","NAGE","SQMX","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653277476","title":"Niagen Bioscience Schedules Q2 Earnings Call After Market Close","url":"https://stock-news.laohu8.com/highlight/detail?id=2653277476","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653277476?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:32","pubTimestamp":1784637143,"startTime":"0","endTime":"0","summary":"Niagen Bioscience schedules Q2 earnings call after market closeNiagen Bioscience schedules Q2 2026 results release for Tuesday, Aug. 4, 2026.Earnings conference call, Tuesday, Aug. 4, 2026 at 4:30 p.m","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nNDL7nG84j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4121","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653277253","title":"Press Release: Niagen Bioscience to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2653277253","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653277253?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:32","pubTimestamp":1784637120,"startTime":"0","endTime":"0","summary":"LOS ANGELES--(BUSINESS WIRE)--July 21, 2026--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, toda","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","NAGE","BK4099","BK4555","BK4588","BK4183","03160","BK4604","BK4121","BK4585","BK4232","BK4022","TM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651544413","title":"Niagen Bioscience Names Abhijit Kale Senior Director of Global External Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2651544413","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651544413?lang=en_us&edition=fundamental","pubTime":"2026-07-16 20:37","pubTimestamp":1784205423,"startTime":"0","endTime":"0","summary":"Niagen Bioscience names Abhijit Kale senior director of global external researchNiagen Bioscience named Abhijit Kale as senior director of global external research, effective July 20, 2026.Kale will r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDLccw2SH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE","BK4183","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651444642","title":"Niagen Bioscience Appoints Abhijit Kale, Ph.d., as Senior Director of Global External Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2651444642","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651444642?lang=en_us&edition=fundamental","pubTime":"2026-07-16 20:32","pubTimestamp":1784205120,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nTUA8CQYTY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","BK4121","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651114994","title":"Niagen Bioscience's NB4168 Gets US FDA Rare Pediatric Disease Tag for Ataxia Telangiectasia","url":"https://stock-news.laohu8.com/highlight/detail?id=2651114994","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651114994?lang=en_us&edition=fundamental","pubTime":"2026-07-13 21:04","pubTimestamp":1783947847,"startTime":"0","endTime":"0","summary":"Niagen Bioscience  has received rare pediatric disease designation from the US Food and Drug Administration for NB4168 in treating ataxia telangiectasia, a multisystem disorder, the company said Monday.The European Medicines Agency also granted Orphan Medicinal Product Designation to NB4168 for the same indication, the company said.The regulatory designations provide incentives to support the drug's development for the rare disease, the company added.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4121","NAGE","LABU","BK4183","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651111777","title":"Niagen Rises After U.S., EU Rare Disease Designations for Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2651111777","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651111777?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:49","pubTimestamp":1783946985,"startTime":"0","endTime":"0","summary":"BUZZ-Niagen rises after U.S., EU rare disease designations for drug candidate** Shares of biotech firm Niagen BioscienceNAGE.Orise 2.6% to $3.47 premarket** Co says its experimental drug, NB4168, rece","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nL4N43F12L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE","BK4121","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651111259","title":"Niagen Bioscience receives exclusive U.S. RPD, EMA OMPD for NB4168","url":"https://stock-news.laohu8.com/highlight/detail?id=2651111259","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651111259?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:35","pubTimestamp":1783946107,"startTime":"0","endTime":"0","summary":"Niagen Bioscience (NAGE) announced that the U.S. Food & Drug Administration, FDA, granted Rare Pediatric Disease, RPD, Designation for its propriet...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-receives-exclusive-u-s-rpd-ema-ompd-for-nb4168-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-receives-exclusive-u-s-rpd-ema-ompd-for-nb4168-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4081","BK4121","LABU","BK4097","EMA","BK4585","NAGE","LU1878469433.USD","BK4183","RPD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651111606","title":"Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (rpd) Designation and European Medicines Agency Orphan Medicinal Product Designation (ompd) for Nb4168 for the Treatment of Ataxia Telangiectasia (a-t)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651111606","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651111606?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:32","pubTimestamp":1783945920,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nTUA13G7ZY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NAGE","BK4183","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649348999","title":"Niagen Bioscience Launches Program to Develop Therapies for Accelerated Aging and Rare Genetic Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2649348999","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649348999?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:17","pubTimestamp":1783516678,"startTime":"0","endTime":"0","summary":"Niagen Bioscience  said Wednesday that its NAD Pharmaceuticals unit will undertake a pharmaceutical program to develop therapies for accelerated aging and rare genetic diseases.The program will primarily focus on how NAD+, a coenzyme vital for energy metabolism, DNA repair, mitochondrial function and cellular stress responses, modulates in rare diseases for which DNA misrepair and mitochondrial dysfunction are foundational underlying causes, the company said.Niagen said that NB4168, a derivative of the NAD+ precursor nicotinamide riboside, is the first investigational pharmaceutical product candidate within the program, with Ataxia Telangiectasia as the initial indication.Shares of the company were up 1.5% in Wednesday's premarket trading.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4183","BK4121","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649996849","title":"Niagen Bioscience launches pharmaceutical program for aging and genetic diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2649996849","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649996849?lang=en_us&edition=fundamental","pubTime":"2026-07-08 20:40","pubTimestamp":1783514425,"startTime":"0","endTime":"0","summary":"Niagen Bioscience (NAGE) formally launched the first drug candidate of NAD Pharmaceuticals, its wholly owned subsidiary focused on developing thera...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-launches-pharmaceutical-program-for-aging-and-genetic-diseases-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-launches-pharmaceutical-program-for-aging-and-genetic-diseases-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4183","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649067608","title":"Niagen Bioscience initiated with a Buy at Freedom Broker","url":"https://stock-news.laohu8.com/highlight/detail?id=2649067608","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649067608?lang=en_us&edition=fundamental","pubTime":"2026-07-07 03:10","pubTimestamp":1783365021,"startTime":"0","endTime":"0","summary":"Freedom Broker analyst Ilya Zubkov initiated coverage of Niagen Bioscience (NAGE) with a Buy rating and $9 price target The firm calls Niagen “a be...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-initiated-with-a-buy-at-freedom-broker-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-initiated-with-a-buy-at-freedom-broker-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4183","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647075723","title":"Niagen Bioscience Shareholders Back Board and Governance Measures","url":"https://stock-news.laohu8.com/highlight/detail?id=2647075723","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647075723?lang=en_us&edition=fundamental","pubTime":"2026-06-30 05:03","pubTimestamp":1782767001,"startTime":"0","endTime":"0","summary":"Niagen Bioscience ( ($NAGE) ) just unveiled an update. At Niagen Bioscience’s 2026 Annual Meeting of Stockholders, shareholders elected eight direc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/niagen-bioscience-shareholders-back-board-and-governance-measures?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/niagen-bioscience-shareholders-back-board-and-governance-measures?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4183","NAGE","BK4121"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.niagenplus.com","stockEarnings":[{"period":"1week","weight":0.0592},{"period":"1month","weight":0.021},{"period":"3month","weight":-0.299},{"period":"6month","weight":-0.4324},{"period":"1year","weight":-0.6364},{"period":"ytd","weight":-0.4654}],"compareEarnings":[{"period":"1week","weight":0.011},{"period":"1month","weight":0.0017},{"period":"3month","weight":0.0366},{"period":"6month","weight":0.0796},{"period":"1year","weight":0.1819},{"period":"ytd","weight":0.0955}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":" ","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.045249},{"month":2,"riseRate":0.5,"avgChangeRate":0.181088},{"month":3,"riseRate":0.3,"avgChangeRate":0.049759},{"month":4,"riseRate":0.6,"avgChangeRate":0.039691},{"month":5,"riseRate":0.454545,"avgChangeRate":0.002402},{"month":6,"riseRate":0.545455,"avgChangeRate":0.046268},{"month":7,"riseRate":0.545455,"avgChangeRate":-0.000754},{"month":8,"riseRate":0.3,"avgChangeRate":-0.041379},{"month":9,"riseRate":0.3,"avgChangeRate":-0.054309},{"month":10,"riseRate":0.2,"avgChangeRate":-0.056092},{"month":11,"riseRate":0.7,"avgChangeRate":0.200397},{"month":12,"riseRate":0.3,"avgChangeRate":-0.024057}],"exchange":"NASDAQ","name":"Niagen Bioscience","nameEN":"Niagen Bioscience"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.0","shortVersion":"4.47.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Niagen Bioscience(NAGE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Niagen Bioscience(NAGE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Niagen Bioscience,NAGE,Niagen Bioscience股票,Niagen Bioscience股票老虎,Niagen Bioscience股票老虎国际,Niagen Bioscience行情,Niagen Bioscience股票行情,Niagen Bioscience股价,Niagen Bioscience股市,Niagen Bioscience股票价格,Niagen Bioscience股票交易,Niagen Bioscience股票购买,Niagen Bioscience股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Niagen Bioscience(NAGE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Niagen Bioscience(NAGE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction